Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John K Field

Showing results (11-20 of 258) with videos related to

Pageof 26
Sort By:
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
The Lancet. Oncology|March 25, 2016
Lung cancer CT screening: is annual screening necessary?John K Field, Stephen W Duffy
The Lancet Regional Health. Europe|December 24, 2021
Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' replyStephen W Duffy, John K Field
Respiratory Research|May 18, 2016
Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology groupFrances C Sherratt, Lisa Newson, John K Field
Translational Lung Cancer Research|March 24, 2017
Risk assessment in relation to the detection of small pulmonary nodulesJohn K Field, Michael W Marcus, Matthijs Oudkerk
Oncology Reports|August 3, 2017
Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review)Caroline E McCarthy, John K Field, Michael W Marcus
Translational Lung Cancer Research|May 22, 2018
Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening TrialJohn K Field, Stephen W Duffy, David R Baldwin
The Lancet. Oncology|September 23, 2008
A global approach to cancer-screening trialsRobert A Smith, John K Field, Stephen W Duffy
Annals of Internal Medicine|April 3, 2013
In response. Predictive accuracy of the Liverpool Lung Project risk modelJohn K Field, Olaide Y Raji, Stephen W Duffy
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2025
External validation of plasma glycosaminoglycans as biomarkers to improve lung cancer risk stratificationMichael P A Davies, John K Field, Francesco Gatto
Pageof 26

Showing results (11-20 of 258) with videos related to

Sort By:
Pageof 26
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
The Lancet. Oncology|March 25, 2016
Lung cancer CT screening: is annual screening necessary?John K Field, Stephen W Duffy
The Lancet Regional Health. Europe|December 24, 2021
Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' replyStephen W Duffy, John K Field
Respiratory Research|May 18, 2016
Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology groupFrances C Sherratt, Lisa Newson, John K Field
Translational Lung Cancer Research|March 24, 2017
Risk assessment in relation to the detection of small pulmonary nodulesJohn K Field, Michael W Marcus, Matthijs Oudkerk
Oncology Reports|August 3, 2017
Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review)Caroline E McCarthy, John K Field, Michael W Marcus
Translational Lung Cancer Research|May 22, 2018
Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening TrialJohn K Field, Stephen W Duffy, David R Baldwin
The Lancet. Oncology|September 23, 2008
A global approach to cancer-screening trialsRobert A Smith, John K Field, Stephen W Duffy
Annals of Internal Medicine|April 3, 2013
In response. Predictive accuracy of the Liverpool Lung Project risk modelJohn K Field, Olaide Y Raji, Stephen W Duffy
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2025
External validation of plasma glycosaminoglycans as biomarkers to improve lung cancer risk stratificationMichael P A Davies, John K Field, Francesco Gatto
Pageof 26